Personalized Peptide Protocols with BPC-157 from Rafael Olartecoechea, ARNP Your journey to a healthier weight requires personalized attention
Factoring in research and development, clinical trials in human subjects and finally safety reviews, new drugs take an average of a decade or more to receive FDA approval, he said
Separate-Vial Reconstitution Spec BAC water added BPC-157 (10 mg vial) 2.0 mL TB-500 (10 mg vial) 2.0 mL Spec Final concentration BPC-157 (10 mg vial) 5.0 mg/mL TB-500 (10 mg vial) 5.0 mg/mL Spec 10 units (0.10 mL) delivers BPC-157 (10 mg vial) 500 mcg TB-500 (10 mg vial) 500 mcg Spec 20 units (0.20 mL) delivers BPC-157 (10 mg vial) 1.0 mg TB-500 (10 mg vial) 1.0 mg Spec Doses per vial (typical) BPC-157 (10 mg vial) ~2040 days TB-500 (10 mg vial) ~45 loading doses This separate-vial row keeps the same 10 mg-per-compound assumption as the 20 mg pre-blend, but the compounds are reconstituted and drawn independently
For hip labral tears, which involve similar fibrocartilaginous tissue, this research suggests the peptide might support more complete healing than typically occurs naturally
1 3
Interestingly, reducing chronic inflammation may be an indirect way of reducing 5-alpha reductase